Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry Ma

Showing results (151-160 of 180) with videos related to

Pageof 18
Sort By:
International Journal of Stroke : Official Journal of the International Stroke Society|December 10, 2024
Extending the time window for tenecteplase by effective reperfusion of penumbral tissue in patients with large vessel occlusion: Rationale and design of a multicenter, prospective, randomized, open-label, blinded-endpoint, controlled phase 3 trialVignan Yogendrakumar, Bruce Cv Campbell, Leonid Churilov, et al.
JAMA Neurology|November 2, 2020
Association of Reperfusion After Thrombolysis With Clinical Outcome Across the 4.5- to 9-Hours and Wake-up Stroke Time Window: A Meta-Analysis of the EXTEND and EPITHET Randomized Clinical TrialsBruce C V Campbell, Henry Ma, Mark W Parsons, et al.
Stroke|December 22, 2020
Utility of Severity-Based Prehospital Triage for Endovascular Thrombectomy: ACT-FAST Validation StudyHenry Zhao, Karen Smith, Stephen Bernard, et al.
Stroke|September 10, 2025
Efficacy of Tenecteplase in Large Vessel Occlusion Stroke Within 24 Hours of Symptom Onset: The ETERNAL-LVO Randomized Controlled TrialVignan Yogendrakumar, Bruce C V Campbell, Leonid Churilov, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|March 26, 2017
Cholesterol Levels Are Associated with 30-day Mortality from Ischemic Stroke in Dialysis PatientsI-Kuan Wang, Chung-Hsiang Liu, Tzung-Hai Yen, et al.
NEJM Evidence|December 22, 2025
A Randomized Trial of Telemedicine Models of Care on a Mobile Stroke UnitVignan Yogendrakumar, Anna H Balabanski, Hannah Johns, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|December 23, 2011
A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND)Henry Ma, Mark W Parsons, Soren Christensen, et al.
The Lancet. Neurology|May 7, 2022
Comparison of tenecteplase with alteplase for the early treatment of ischaemic stroke in the Melbourne Mobile Stroke Unit (TASTE-A): a phase 2, randomised, open-label trialAndrew Bivard, Henry Zhao, Leonid Churilov, et al.
Stroke|February 21, 2020
Melbourne Mobile Stroke Unit and Reperfusion Therapy: Greater Clinical Impact of Thrombectomy Than ThrombolysisHenry Zhao, Skye Coote, Damien Easton, et al.
Lancet (London, England)|July 10, 2022
Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4·5 h of stroke onset: an open-label, blinded-endpoint, randomised non-inferiority trialPeter J Mitchell, Bernard Yan, Leonid Churilov, et al.
Pageof 18

Showing results (151-160 of 180) with videos related to

Sort By:
Pageof 18
International Journal of Stroke : Official Journal of the International Stroke Society|December 10, 2024
Extending the time window for tenecteplase by effective reperfusion of penumbral tissue in patients with large vessel occlusion: Rationale and design of a multicenter, prospective, randomized, open-label, blinded-endpoint, controlled phase 3 trialVignan Yogendrakumar, Bruce Cv Campbell, Leonid Churilov, et al.
JAMA Neurology|November 2, 2020
Association of Reperfusion After Thrombolysis With Clinical Outcome Across the 4.5- to 9-Hours and Wake-up Stroke Time Window: A Meta-Analysis of the EXTEND and EPITHET Randomized Clinical TrialsBruce C V Campbell, Henry Ma, Mark W Parsons, et al.
Stroke|December 22, 2020
Utility of Severity-Based Prehospital Triage for Endovascular Thrombectomy: ACT-FAST Validation StudyHenry Zhao, Karen Smith, Stephen Bernard, et al.
Stroke|September 10, 2025
Efficacy of Tenecteplase in Large Vessel Occlusion Stroke Within 24 Hours of Symptom Onset: The ETERNAL-LVO Randomized Controlled TrialVignan Yogendrakumar, Bruce C V Campbell, Leonid Churilov, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|March 26, 2017
Cholesterol Levels Are Associated with 30-day Mortality from Ischemic Stroke in Dialysis PatientsI-Kuan Wang, Chung-Hsiang Liu, Tzung-Hai Yen, et al.
NEJM Evidence|December 22, 2025
A Randomized Trial of Telemedicine Models of Care on a Mobile Stroke UnitVignan Yogendrakumar, Anna H Balabanski, Hannah Johns, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|December 23, 2011
A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND)Henry Ma, Mark W Parsons, Soren Christensen, et al.
The Lancet. Neurology|May 7, 2022
Comparison of tenecteplase with alteplase for the early treatment of ischaemic stroke in the Melbourne Mobile Stroke Unit (TASTE-A): a phase 2, randomised, open-label trialAndrew Bivard, Henry Zhao, Leonid Churilov, et al.
Stroke|February 21, 2020
Melbourne Mobile Stroke Unit and Reperfusion Therapy: Greater Clinical Impact of Thrombectomy Than ThrombolysisHenry Zhao, Skye Coote, Damien Easton, et al.
Lancet (London, England)|July 10, 2022
Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4·5 h of stroke onset: an open-label, blinded-endpoint, randomised non-inferiority trialPeter J Mitchell, Bernard Yan, Leonid Churilov, et al.
Pageof 18